Introducing CleraFlex™, the world’s first stretchable wound dressing.
Today, GelSana is proud to bring CleraFlex to market.
Chronic and difficult-to-heal wounds including diabetic foot ulcers, pressure injuries, venous leg ulcers, surgical incisions, and second-degree burns affect tens of millions of people worldwide. Standard dressings don’t address the underlying biology of difficult wounds.
CleraFlex does.
CleraFlex is built on zwitterionic polymer technology: moldable, stretchable, and designed to support the body’s natural healing process. This product’s physical properties allow it to conform to irregular wound beds, fill wound depth, and move with the patient’s anatomy. CleraFlex supports the body’s natural healing process with reduced inflammation, reduces bacterial adhesion, supports autolytic debridement, and balances wound fluid. All without triggering the immune response that stalls healing in difficult wounds. It keeps the wound environment exactly where it needs to be.
It’s delivered in a single-use syringe. One pouch. Three applications. Clean, precise, and adaptable to any wound geometry.
We built this for the patients who have been underserved by decades of incremental wound care innovation. We hope it shows.
Available now. Learn more at gelsanatherapeutics.com.
This is just the beginning. We are proud of what is in this syringe — and even more excited about where this technology goes next.
GelSana is actively pursuing partnerships with distributors, healthcare systems, and strategic investors to accelerate market access. The company is also advancing its pipeline into additional wound care indications.
For commercial inquiries, partnership opportunities, or investor relations, contact info@gelsanatherapeutics.com or visit gelsanatherapeutics.com.
